1. Enhanced relaxivity of GdIII-complexes with HP-DO3A-like ligands upon the activation of the intramolecular catalysis of the prototropic exchange
- Author
-
Eliana Gianolio, Attila Forgács, Silvio Aime, Franco Fedeli, Luciano Lattuada, Alberto Fringuello Mingo, Zsolt Baranyai, Paolo Minazzi, Giovanni B. Giovenzana, Attila Bényei, Dávid Horváth, and Sonia Colombo Serra
- Subjects
medicine.diagnostic_test ,Gadolinium ,Relaxation (NMR) ,chemistry.chemical_element ,Magnetic resonance imaging ,Diagnostic accuracy ,010402 general chemistry ,01 natural sciences ,030218 nuclear medicine & medical imaging ,0104 chemical sciences ,Catalysis ,Inorganic Chemistry ,03 medical and health sciences ,0302 clinical medicine ,Nuclear magnetic resonance ,chemistry ,Intramolecular force ,medicine - Abstract
Gadolinium(III) complexes have been employed for more than 30 years as contrast agents in magnetic resonance imaging (MRI). In order to further improve the diagnostic accuracy of enhanced magnetic resonance images or to provide comparable enhancement at a reduced administered dose, current research is focusing on the development of GdIII-complexes characterized by higher relaxivity. In this study we describe the synthesis and the equilibrium, kinetic, relaxation and structural properties of two new GdIII-complexes based on modified 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (HP-DO3A) structure which, due to an intramolecular prototropic exchange, display more than two-fold higher relaxivity compared to currently available GdIII-based MRI contrast agents.
- Published
- 2021
- Full Text
- View/download PDF